MYLAN 2045 MYLAN 2045 (Tacrolimus 0.5 mg)

Pill imprint MYLAN 2045 MYLAN 2045 has been identified as Tacrolimus 0.5 mg.

Tacrolimus is used in the treatment of organ transplant, rejection reversal; organ transplant, rejection prophylaxis; graft-versus-host disease; crohn's disease and belongs to the drug class calcineurin inhibitors. Risk cannot be ruled out during pregnancy. Tacrolimus 0.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Tacrolimus

Imprint:

MYLAN 2045 MYLAN 2045

Strength:

0.5 mg

Color:

Orange / Gray

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Calcineurin inhibitors

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Mylan Pharmaceuticals Inc.

National Drug Code (NDC):

00378-2045

Inactive Ingredients:

lactose anhydrous
ferrosoferric oxide
silicon dioxide
croscarmellose sodium
gelatin
hypromelloses
lactose monohydrate
magnesium stearate
sodium lauryl sulfate
titanium dioxide
ferric oxide yellow
D&C Red No. 28
D&C Yellow No. 10
FD&C Red No. 40
FD&C Blue No. 1
FD&C Blue No. 2
propylene glycol
shellac

Note: Inactive ingredients may vary.

Imprint Code FAQ's

Other Manufacturers / Repackagers:

NDC Code	Manufacturer / Repackager
51079-0817	UDL Laboratories Inc

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.